Here are the S-3 shelf registrations from SmartKem, Inc. (SMTK) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
An S-3 covers the shelf registration that lets an established company sell over time, so if you follow SMTK and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full SMTK filings page.
SmartKem, Inc. (SMTK) is registering, for resale by existing investors, up to 15,127,662 shares of common stock, including 2,516,786 shares issuable on conversion of Series A preferred stock, 161,313 warrant shares, and 12,449,563 additional registration-rights shares. SmartKem itself is not selling shares and will receive no proceeds from these resales, other than any cash paid upon warrant exercises, which are earmarked for general working capital.
SmartKem recently completed a 1‑for‑50 reverse stock split effective August 20, 2026, and now has authorized capital of 5,000,000,000 common shares plus 10,000,000 preferred shares, including 31,412 authorized Series A preferred. The company agreed to an all‑stock Business Combination to acquire Ferrox Critical Minerals, Ltd. for approximately $125 million, subject to shareholder approvals, Nasdaq listing of the new shares, effectiveness of a Form S‑4, and other customary conditions; the agreement may be terminated if not completed by March 31, 2027 and includes a $3 million termination fee payable by SmartKem in certain circumstances.
To support Ferrox, SmartKem has provided several convertible bridge loans totaling multiple millions of dollars in principal at 5.0% interest, maturing December 31, 2026, with conversion rights into Ferrox equity and associated rights of first refusal and exclusivity through that date. SmartKem also highlights that its auditors’ reports for 2024 and 2025 include going‑concern explanatory paragraphs regarding its ability to continue as a going concern, and that completing the Ferrox transaction is uncertain and subject to numerous risks, including potential shareholder dilution and possible liquidation of SmartKem if strategic alternatives fail.
SmartKem, Inc. filed an amendment to a Form S-3 to register 160,260,999 shares of Common Stock for resale by selling stockholders. The registered shares comprise 47,596,389 Additional Conversion Shares, 10,753,615 Additional Warrant Shares, and 101,910,995 Additional RRA Shares.
The prospectus states the company will not receive proceeds from resales by selling stockholders but will receive net proceeds from any Warrants exercised for cash. The filing also discloses recent financings and transactions, including an Equity Line providing up to $500,000,000 or 19.99% of shares, a $3,750,000 senior secured note issuance, and a $300,000 settlement payment tied to patent assignments. Shares trade on Nasdaq under the symbol SMTK, last reported at $0.2364 on July 1, 2026.
SmartKem, Inc. filed a shelf registration to permit resale of up to 160,260,999 shares of Common Stock by selling stockholders pursuant to private placements and related transactions, including 47,596,389 Additional Conversion Shares, 10,753,615 Additional Warrant Shares and 101,910,995 Additional RRA Shares. The company will not receive proceeds from these resales but will receive net proceeds if any warrants are exercised for cash.
The filing discloses recent financings and strategic transactions: an equity line of credit commitment up to $500,000,000 or 19.99% of outstanding shares, senior secured notes with an original principal of $3,750,000 (issued at a purchase price of $2,625,000), a $300,000 settlement payment and related patent assignment, and various private placements and conversions completed earlier in 2026.
SmartKem, Inc. is registering 126,453,978 shares of Common Stock for resale by selling stockholders, comprised of 101,910,996 Conversion Shares issuable upon conversion of newly designated Series A Convertible Preferred Stock and 24,542,982 Warrant Shares issuable upon exercise of warrants. The company itself is not selling shares here and will not receive proceeds from resales; however, SmartKem will receive net proceeds from any Warrants exercised for cash. The prospectus discloses an equity line with Keystone allowing up to $500,000,000 or 19.99% of outstanding shares (reduced by certain issuances), a senior secured notes financing with original principal $3,750,000 (issued at a ~30% discount), and related settlement and patent assignments tied to prior notes.